ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding ProMIS Neurosciences Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 15 | 16 | +1 |
| Shares | 3.35M | 3.38M | +34.1K (+1.0%) |
| Value | $3.85M | $6.46M | +$2.61M (+67.8%) |
New holders (4)
Institutions that held ProMIS Neurosciences Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 30,366 | $59.8K | 0.00% |
| Hara Capital LLC | 29,416 | $56.2K | 0.03% |
| Sandy Spring Bank | 3,300 | $6.30K | 0.00% |
| Northwestern Mutual Wealth Management Co | 143 | $273 | 0.00% |
Sold out (3)
Institutions that held ProMIS Neurosciences Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Kingsview Wealth Management, LLC | 11,100 | $12.8K |
| TD Waterhouse Canada Inc. | 149 | $281 |
| AllSquare Wealth Management LLC | 185 | $213 |